SORRENTINO, NICOLINA CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 371
EU - Europa 234
AS - Asia 113
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 723
Nazione #
US - Stati Uniti d'America 366
IT - Italia 143
SG - Singapore 67
NL - Olanda 47
CN - Cina 39
SE - Svezia 12
FI - Finlandia 8
IE - Irlanda 7
DE - Germania 6
CA - Canada 5
GB - Regno Unito 5
VN - Vietnam 4
CI - Costa d'Avorio 3
FR - Francia 3
KR - Corea 2
AU - Australia 1
BR - Brasile 1
IN - India 1
MT - Malta 1
PL - Polonia 1
UA - Ucraina 1
Totale 723
Città #
Chandler 90
Naples 61
Singapore 52
Amsterdam 46
Santa Clara 30
Ashburn 17
Napoli 15
Millbury 14
Boston 13
Des Moines 12
Princeton 9
Beijing 8
Lawrence 8
Nanjing 7
Fairfield 6
Shenyang 6
Milan 5
Ottawa 5
Rome 5
Dearborn 4
Dong Ket 4
Avellino 3
Caserta 3
Formia 3
Woodbridge 3
Atlanta 2
Council Bluffs 2
Frankfurt am Main 2
Hebei 2
Jacksonville 2
Nocera Inferiore 2
Salerno 2
San Felice A Cancello 2
San Jose 2
Sarno 2
Wilmington 2
Altamura 1
Ann Arbor 1
Aversa 1
Baronissi 1
Bethesda 1
Boardman 1
Brescia 1
Cava 1
Chicago 1
Dublin 1
Dugenta 1
Fuzhou 1
Houston 1
Icheon-si 1
Ischia 1
Jiaxing 1
Kronberg 1
London 1
Los Angeles 1
Marsa 1
Nanchang 1
New Jersey 1
New York 1
Norwalk 1
Palermo 1
Paris 1
Pescara 1
Redwood City 1
Shanghai 1
St Andrews 1
Sydney 1
Tacoma 1
Tianjin 1
Verona 1
Viamão 1
Washington 1
Zola Predosa 1
Totale 488
Nome #
Retinal Degeneration in MPS-IIIA Mouse Model 157
Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases 56
Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders 50
Enhanced Version of Human Sulfamidase Significantly Ameliorates CNS Pathology When Delivered to the MPS-IIIA Mice by AAV-Mediated Intra-CSF Injection 50
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 43
A comprehensive map of CNS transduction by eight recombinant adeno-associated virus serotypes upon cerebrospinal fluid administration in pigs 41
Access to cerebrospinal fluid in piglets via the cisterna magna: Optimization and description of the technique 40
Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice 40
A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA. 36
Brain Targeting in MPS-IIIA 36
The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease 36
Efficacy of a combined intracerebral and systemic gene delivery approach for the treatment of a severe lysosomal storage disorder. 35
Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIA 34
Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatments. 30
Transdermal spinal catheter placement in piglets: Description and validation of the technique. 27
Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches 27
Fluoxetine ameliorates mucopolysaccharidosis type IIIA 25
Therapy of sulfatase deficiencies 23
New mouse models with hypomorphic SUMF1 variants mimic attenuated forms of multiple sulfatase deficiency 22
Role of trafficking protein particle complex 2 in medaka development 18
Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIA 17
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis 17
Increased expression or activation of TRPML1 reduces hepatic storage of toxic Z alpha-1 antitrypsin 17
Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases 11
Totale 888
Categoria #
all - tutte 3.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020169 0 0 0 0 15 1 7 1 129 6 6 4
2020/202134 1 1 7 0 7 4 2 1 5 1 1 4
2021/202288 1 0 0 0 1 4 0 1 8 2 23 48
2022/2023213 20 25 5 12 30 19 9 14 27 39 10 3
2023/2024157 13 25 44 7 8 11 2 8 3 5 20 11
2024/2025134 31 55 4 16 28 0 0 0 0 0 0 0
Totale 888